Updated September 2, 2025
Fatigue: Some individuals may feel more tired than usual, especially during the early stages of taking the medication
Can women use TB-500 or GHK-Cu
Final Verdict: Research Comparison Feature Tirzepatide Retatrutide Receptor Targets GLP-1, GIP GLP-1, GIP, Glucagon Half-Life ~5 Days ~6 Days Max Published Weight Loss ~21% (72w) ~24% (48w) Liver Fat Reduction Moderate/High Extreme Primary Research Focus Glycemic Control Metabolic Reset / REE Future Outlook: Post-2025 Research Landscape As we look toward 2026 and beyond, the data from the Phase 3 TRIUMPH trials will likely solidify retatrutides position in the metabolic research hierarchy
Combining genetic insights with baseline metabolic markers (fasting insulin, glucose, HbA1c) and body composition assessment allows your provider to set personalized expectations for tirzepatide response timing
Eli Lilly offers savings cards that bring monthly costs as low as $25 USD for commercially insured patients